For Professionals

Explore a New Frontier in Patient Care with Dreamscape Ketamine

Leverage innovative ketamine therapies to expand treatment capabilities of your practice.

Experience rapid symptom relief through evidence-based protocols.

Join a supportive network for continuous professional development.

Why Ketamine?

Understanding the Breakthrough Treatment

Ketamine, an NMDA receptor antagonist with rapid-acting antidepressant properties, is at the forefront of treating chronic affective disorders due to its neuroplasticity-inducing and glutamatergic modulation effects.¹

¹

Zarate Jr, C. A., et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856-864.

Referral Benefits

Why Partner with Us?

Improve patient success and satisfaction through collaboration. 

Comprehensive Care Model

Holistic Treatment for Optimal Results

Our integrated care model incorporates personalized ketamine protocols, enhancing traditional treatment pathways and fostering neurobiological resilience.²

²

Abdallah, C. G., et al. (2015). Ketamine’s mechanism of action: A path to rapid-acting antidepressants. Depression and Anxiety, 32(8), 557-566.

Hear from Our Partners & Patients

Success Stories in Collaboration

Our clinical collaborations underscore the transformative impact of ketamine therapy as an adjunct treatment, with substantial improvements in treatment-resistant conditions.

[trustindex no-registration=google]

Professional Development

Grow with Our Support

Benefit from our comprehensive education programs, including seminars and workshops on the latest in psychopharmacology and ketamine therapy, designed to enhance your practice and patient outcomes.

Our Services

A Spectrum of Innovative Treatments

We offer a range of ketamine-based treatments, with protocols grounded in the latest research to ensure tailored and effective care for chronic pain and affective disorders.³

Feder, A., et al. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry, 71(6), 681-688.

The Dreamscape Ketamine Difference

Where Healing Meets Innovation

As clinical trailblazers, we prioritize our partners’ practice growth, supported by evidence-based treatments, fostering an environment of shared scientific advancement and patient-centric care.

Join Our Professional Referral Network

Join Our Professional Referral Network

Become part of a thriving network that values professional insights and collaborative care. Joining is straightforward—start by reaching out to us today.

How can we help?

Choose from the following options